Evidence from economic evaluations and broader health technology assessments (HTAs) can be useful to inform difficult decisions in priority setting and health sector resource allocation. Globally, there has been a growth in the systematic incorporation of economic evidence in healthcare decision making, particularly in high-income countries (HICs). More recently, this trend has also been observed in low- and middle-income countries (LMICs), where there has been a steady growth in the number of economic evaluation studies. Nevertheless, formal structures and processes for the systematic utilization of economic evidence to inform decision making are less evident in these settings. 6-8 This has become an important agenda item because LMICs aim to develop equitable and sustainable healthcare systems for delivering universal health coverage.

Read PDF: VALUE IN HEALTH REGIONAL ISSUES 19 (2019) 65 - 74